Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
シアトル
+1 415 439 1799シアトル
Capabilities
Suggested News & Insights
Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026Connecting Clusters of Excellence: Europe as Your Gateway to Global Success – Organized by Biovia, Health Campus Limburg DC, SidleyMonday, January 12, 2026#DrugPricing: More Average Sales Price Proposals and New Comment PeriodJanuary 6, 2026Sidley Represents BioRender in Investment Valuing Company at $900 MillionJanuary 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory